$6.40
12.28% day before yesterday
Nasdaq, Nov 26, 09:29 pm CET
ISIN
US68373L2088
Symbol
OPGN

OpGen, Inc. Stock price

$6.40
+6.40 711,011.11% 1M
+1.70 36.17% 6M
+5.81 975.63% YTD
+4.86 315.58% 1Y
-27.66 81.21% 3Y
-393.60 98.40% 5Y
-170,993.60 100.00% 10Y
-484,993.60 100.00% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
+0.70 12.28%
ISIN
US68373L2088
Symbol
OPGN
Industry

Key metrics

Basic
Market capitalization
$64.5m
Enterprise Value
$63.6m
Net debt
positive
Cash
$830.0k
Shares outstanding
10.1m
Valuation (TTM | estimate)
P/E
4.2 | -
P/S
7.2 | -
EV/Sales
7.1 | -
EV/FCF
negative
P/B
6.0
Financial Health
Equity Ratio
74.8%
Return on Equity
153.9%
ROCE
53.0%
ROIC
54.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$9.0m | -
EBITDA
$6.8m | -
EBIT
$6.6m | -
Net Income
$15.6m | -
Free Cash Flow
$-3.7m
Growth (TTM | estimate)
Revenue
322.5% | -
EBITDA
168.7% | -
EBIT
162.6% | -
Net Income
170.9% | -
Free Cash Flow
42.1%
Margin (TTM | estimate)
Gross
100.0%
EBITDA
75.1% | -
EBIT
73.0%
Net
172.8% | -
Free Cash Flow
-41.2%
More
EPS
$1.5
FCF per Share
$-0.4
Short interest
1.8%
Employees
93
Rev per Employee
$60.0k
Show more

Is OpGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

OpGen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a OpGen, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a OpGen, Inc. forecast:

Hold
50%
Sell
50%

Financial data from OpGen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9 9
323% 323%
100%
- Direct Costs - -
-
-
9 9
5,525% 5,525%
100%
- Selling and Administrative Expenses 2.43 2.43
73% 73%
27%
- Research and Development Expense - -
-
-
6.75 6.75
169% 169%
75%
- Depreciation and Amortization 0.18 0.18
74% 74%
2%
EBIT (Operating Income) EBIT 6.57 6.57
163% 163%
73%
Net Profit 16 16
171% 171%
173%

In millions USD.

Don't miss a Thing! We will send you all news about OpGen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Head office United States
CEO Hon Tan
Employees 93
Founded 2001
Website opgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today